BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 34050697)

  • 1. Clonal hematopoiesis associated with epigenetic aging and clinical outcomes.
    Nachun D; Lu AT; Bick AG; Natarajan P; Weinstock J; Szeto MD; Kathiresan S; Abecasis G; Taylor KD; Guo X; Tracy R; Durda P; Liu Y; Johnson C; Rich SS; Van Den Berg D; Laurie C; Blackwell T; Papanicolaou GJ; Correa A; Raffield LM; Johnson AD; Murabito J; Manson JE; Desai P; Kooperberg C; Assimes TL; Levy D; Rotter JI; Reiner AP; Whitsel EA; Wilson JG; Horvath S; Jaiswal S;
    Aging Cell; 2021 Jun; 20(6):e13366. PubMed ID: 34050697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influences of DNA methylation and epigenetic clocks, on metabolic disease, in middle-aged Koreans.
    Lee HS; Park T
    Clin Epigenetics; 2020 Oct; 12(1):148. PubMed ID: 33059731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
    Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
    J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
    Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
    JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.
    Tobias DK; Manning AK; Wessel J; Raghavan S; Westerman KE; Bick AG; Dicorpo D; Whitsel EA; Collins J; Correa A; Cupples LA; Dupuis J; Goodarzi MO; Guo X; Howard B; Lange LA; Liu S; Raffield LM; Reiner AP; Rich SS; Taylor KD; Tinker L; Wilson JG; Wu P; Carson AP; Vasan RS; Fornage M; Psaty BM; Kooperberg C; Rotter JI; Meigs J; Manson JE;
    Diabetes Care; 2023 Nov; 46(11):1978-1985. PubMed ID: 37756531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease.
    Uddin MDM; Nguyen NQH; Yu B; Brody JA; Pampana A; Nakao T; Fornage M; Bressler J; Sotoodehnia N; Weinstock JS; Honigberg MC; Nachun D; Bhattacharya R; Griffin GK; Chander V; Gibbs RA; Rotter JI; Liu C; Baccarelli AA; Chasman DI; Whitsel EA; Kiel DP; Murabito JM; Boerwinkle E; Ebert BL; Jaiswal S; Floyd JS; Bick AG; Ballantyne CM; Psaty BM; Natarajan P; Conneely KN
    Nat Commun; 2022 Sep; 13(1):5350. PubMed ID: 36097025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal hematopoiesis and associated diseases: A review of recent findings.
    Asada S; Kitamura T
    Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal hematopoiesis of indeterminate potential in patients with acute coronary syndrome undergoing percutaneous coronary intervention in the absence of traditional risk factors.
    Jiang Z; Li Y; Yan C; Zhang X; Zhang Q; Li J; Tian X; Qiu M; Liang Z; Ma S; Na K; Li Z; Chen S; Zhao Y; Qi Z; Liu X; Han Y
    Clin Res Cardiol; 2023 Apr; 112(4):506-517. PubMed ID: 35704087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk.
    Wang T; Maden SK; Luebeck GE; Li CI; Newcomb PA; Ulrich CM; Joo JE; Buchanan DD; Milne RL; Southey MC; Carter KT; Willbanks AR; Luo Y; Yu M; Grady WM
    Clin Epigenetics; 2020 Jan; 12(1):5. PubMed ID: 31900199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
    Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
    J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential.
    Yu X; Qian N; Wang Y
    Mol Biol Rep; 2023 Mar; 50(3):2813-2822. PubMed ID: 36595120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins.
    Soerensen M; Tulstrup M; Hansen JW; Weischenfeldt J; Grønbæk K; Christensen K
    Hemasphere; 2022 Sep; 6(9):e768. PubMed ID: 36046215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere length and epigenetic clocks as markers of cellular aging: a comparative study.
    Pearce EE; Alsaggaf R; Katta S; Dagnall C; Aubert G; Hicks BD; Spellman SR; Savage SA; Horvath S; Gadalla SM
    Geroscience; 2022 Jun; 44(3):1861-1869. PubMed ID: 35585300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of Clonal Hematopoiesis and Risk of Heart Failure.
    Bazeley P; Morales R; Tang WHW
    Curr Heart Fail Rep; 2020 Oct; 17(5):271-276. PubMed ID: 32772279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury.
    Vlasschaert C; Robinson-Cohen C; Chen J; Akwo E; Parker AC; Silver SA; Bhatraju PK; Poisner H; Cao S; Jiang M; Wang Y; Niu A; Siew E; Van Amburg JC; Kramer HJ; Kottgen A; Franceschini N; Psaty BM; Tracy RP; Alonso A; Arking DE; Coresh J; Ballantyne CM; Boerwinkle E; Grams M; Zhang MZ; Kestenbaum B; Lanktree MB; Rauh MJ; Harris RC; Bick AG
    Nat Med; 2024 Mar; 30(3):810-817. PubMed ID: 38454125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Neighborhood Deprivation With Epigenetic Aging Using 4 Clock Metrics.
    Lawrence KG; Kresovich JK; O'Brien KM; Hoang TT; Xu Z; Taylor JA; Sandler DP
    JAMA Netw Open; 2020 Nov; 3(11):e2024329. PubMed ID: 33146735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic measures of ageing predict the prevalence and incidence of leading causes of death and disease burden.
    Hillary RF; Stevenson AJ; McCartney DL; Campbell A; Walker RM; Howard DM; Ritchie CW; Horvath S; Hayward C; McIntosh AM; Porteous DJ; Deary IJ; Evans KL; Marioni RE
    Clin Epigenetics; 2020 Jul; 12(1):115. PubMed ID: 32736664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of biological, social and environmental factors associated with epigenetic clock acceleration.
    Oblak L; van der Zaag J; Higgins-Chen AT; Levine ME; Boks MP
    Ageing Res Rev; 2021 Aug; 69():101348. PubMed ID: 33930583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial.
    Svensson EC; Madar A; Campbell CD; He Y; Sultan M; Healey ML; Xu H; D'Aco K; Fernandez A; Wache-Mainier C; Libby P; Ridker PM; Beste MT; Basson CT
    JAMA Cardiol; 2022 May; 7(5):521-528. PubMed ID: 35385050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
    Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
    JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.